A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. As a science, biomaterials is about fifty years old. Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc.
Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.
The global Collagen and HA-Based Biomaterials market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Collagen and HA-Based Biomaterials volume and value at global level, regional level and company level. From a global perspective, this report represents overall Collagen and HA-Based Biomaterials market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Collagen and HA-Based Biomaterials in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Collagen and HA-Based Biomaterials manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Medical Optics, Inc. (US)
Alcon Laboratories, Inc. (US)
Allergan, Inc. (US)
Anika Therapeutics, Inc. (US)
Bausch & Lomb, Inc. (US)
Collagen Solutions Plc. (UK)
Lifecore Biomedical, LLC (US)
Seikagaku Corp. (Japan)
Teijin Pharma Limited (Japan)
Segment by Regions
Segment by Type
Facial Aesthetic Dermal Fillers
Segment by Application